RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022 2022-12-08 10:11
Protect Bio, the Next Rising Star in the Blue Ocean Market of Companion Animals’ Healthcare 2022-12-08 10:09
RemeGen Looks to Take Next Global Steps During ASN Kidney Week 2022 2022-12-01 14:29
Moving Past Animal Models with Better Data for Drug Discovery 2022-12-01 14:29
Illumina Genomics Forum Highlights – President Obama, Novel Sequencer, Bill Gates 2022-12-01 14:27
Coastar Therapeutics Receives Venture Capital Investment to Further Develop Delivery Technology of Biologics for Cancer and Gene Therapies 2022-11-11 17:09
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene 2022-10-26 17:23
Defeating Head and Neck Cancer, From Combination Therapy to Photoimmunotherapy 2022-09-29 16:31
BIOPLUS-INTERPHEX Korea 2022: The Now and Tomorrow of Korea’s Biotechnology Industry 2022-08-26 11:02
NIH Provides $23 Million to Fund Telehealth Cancer Care Research 2022-08-26 11:00
Single Cell Sequencing – the Current Players 2022-08-10 10:42
Korean Companies Occupying South Korea’s Diverse Biotech Landscape 2022-08-10 10:41
South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview 2022-08-10 10:37
Caliway Biopharmaceutical Announces Achievements in Revolutionary Fat Reduction Therapy 2022-08-10 10:26
BIO Asia-Taiwan 2022: Connecting the Asian Value Chain 2022-07-07 14:21
BIO Asia-Taiwan 2022: Connecting the Asian Value Chain 2022-07-07 14:21
Taiwan’s Biotech Industry Shines at the 2022 BIO International Convention 2022-06-24 16:41
Over 50 Taiwan Organizations to Present at 2022 BIO International Convention 2022-06-09 14:59
CYTENA BPS and Leadgene Bio to Level Up Taiwan’s Protein Drugs Production 2022-06-09 14:54
Bora Pharmaceuticals Expands with Eden Biologics’ CDMO Purchase 2022-05-18 12:05
1 2 3 4 5